Exchange: NASDAQ·Updated 04:07 AM EDT
GDTC logo

GDTCCYTOMED THERAPEUTICS LIMITED

$1.02
$0.03
(3.03%)
Pre-Market
Prev Close $0.99
Mkt Cap$11.71M
Vol9.00
News
all
press releases
News Placeholder
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge PR Newswire VANCOUVER, BC, Oct. 15, 2025 Equity Insider News...
PR Newswire
News Placeholder
Why Did CytoMed Therapeutics Stock Jump 19% Today?
The company said that the proposed acquisition of TC BioPharm will strengthen and deepen its expertise and knowledge in using allogeneic cell therapies for cancer treatment.
Stocktwits
<
...
1
>

Advertisement|Remove ads.